INCIDENCE OF THROMBOEMBOLIC EVENTS IN THE TOFACITINIB RHEUMATOID ARTHRITIS, PSORIASIS, PSORIATIC ARTHRITIS AND ULCERATIVE COLITIS DEVELOPMENT PROGRAMMES

被引：3

作者：

Mease, P. J. ^{[1
,2
]}

Kremer, J. ^{[3
]}

Cohen, S. ^{[4
]}

Curtis, J. R. ^{[5
]}

Charles-Schoeman, C. ^{[6
]}

Loftus, E. V., Jr. ^{[7
]}

Greenberg, J. ^{[8
]}

Palmetto, N. ^{[7
]}

Kanik, K. S. ^{[10
]}

Graham, D. ^{[10
]}

Wang, C. ^{[10
]}

Biswas, P. ^{[9
]}

Chan, G. ^{[11
]}

DeMasi, R. ^{[11
]}

Valdez, H. ^{[9
]}

Hendrikx, T. ^{[11
]}

Jones, T. V. ^{[11
]}

机构：

[1] Swedish Med Ctr, Seattle, WA USA

[2] Univ Washington, Seattle, WA 98195 USA

[3] Albany Med Coll & Ctr Rheumatol, Albany, NY USA

[4] Metroplex Clin Res Ctr, Dallas, TX USA

[5] Univ Alabama Birmingham, Birmingham, AL USA

[6] Univ Calif Los Angeles, Los Angeles, CA USA

[7] Mayo Clin, Rochester, MN USA

[8] Corrona LLC, Southborough, MA USA

[9] Pfizer Inc, New York, NY USA

[10] Pfizer Inc, Groton, CT 06340 USA

[11] Pfizer Inc, Collegeville, PA USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷

关键词：

D O I：

10.1136/annrheumdis-2018-eular.3048

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0243

引用

页码：983 / 983

页数：1

共 50 条

[1] Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data
Mease, Philip
Charles-Schoeman, Christina
Cohen, Stanley
Fallon, Lara
Woolcott, John
Yun, Huifeng
Kremer, Joel
Greenberg, Jeffrey
Malley, Wendi
Onofrei, Alina
Kanik, Keith S.
Graham, Daniela
Wang, Cunshan
Connell, Carol
Valdez, Hernan
Hauben, Manfred
Hung, Eric
Madsen, Ann
Jones, Thomas, V
Curtis, Jeffrey R.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (11) : 1400 - 1413
[2] Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs
Winthrop, Kevin L.
Yndestad, Arne
Henrohn, Dan
Danese, Silvio
Marsal, Sara
Galindo, Maria
Woolcott, John C.
Jo, Hyejin
Kwok, Kenneth
Shapiro, Andrea B.
Jones, Thomas V.
Diehl, Annette
Su, Chinyu
Panes, Julian
Cohen, Stanley B.
RHEUMATOLOGY AND THERAPY, 2023, 10 (02) : 357 - 373
[3] Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs
Kevin L. Winthrop
Arne Yndestad
Dan Henrohn
Silvio Danese
Sara Marsal
Maria Galindo
John C. Woolcott
Hyejin Jo
Kenneth Kwok
Andrea B. Shapiro
Thomas V. Jones
Annette Diehl
Chinyu Su
Julian Panés
Stanley B. Cohen
Rheumatology and Therapy, 2023, 10 : 357 - 373
[4] Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes
Mariette, Xavier
Borchmann, Sven
Aspeslagh, Sandrine
Szekanecz, Zoltan
Charles-Schoeman, Christina
Schreiber, Stefan
Choy, Ernest H. S.
Peyrin-Biroulet, Laurent
Schmalzing, Marc
Tanaka, Yoshiya
ten Cate, Hugo
Westhovens, Rene
van der Woude, C. Janneke
Omoruyi, Edmund V. Ekoka
Faes, Margaux
Masior, Tomasz
Van Hoek, Paul
Watson, Chris
Rudolph, Christine
Stallmach, Andreas
RMD OPEN, 2025, 11 (01):
[5] Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure
Burmester, Gerd R.
Nash, Peter
Sands, Bruce E.
Papp, Kim
Stockert, Lori
Jones, Thomas, V
Tan, Huaming
Madsen, Ann
Valdez, Hernan
Cohen, Stanley B.
RMD OPEN, 2021, 7 (02):
[6] The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis
Damian, Andreea C.
Colaco, Keith
Rohekar, Sherry
Boyd, Tristan
Chandran, Vinod
Gladman, Dafna D.
Cook, Richard
Eder, Lihi
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (03) : 547 - 552
[7] The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis
Damian, Andreea C.
Colaco, Keith
Rohekar, Sherry
Boyd, Tristan
Chandran, Vinod
Gladman, Dafna D.
Cook, Richard
Eder, Lihi
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 53
[8] Incidence of Venous Thromboembolic Events in Patients With Ulcerative Colitis Treated With Tofacitinib in the Ulcerative Colitis Clinical Development Program
Sandborn, William J.
Panes, Julian
Sands, Bruce E.
Reinisch, Walter
Su, Chinyu
Lawendy, Nervin
Koram, Nana
Fan, Haiyun
Jones, Thomas V.
Modesto, Irene
Quirk, Daniel
Danese, Silvio
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S377 - S377
[9] Correspondence to "The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis"
Lin, Ting-Yun
Huang, Yu-Jen
Lin, Yu-Yu
Liaw, Yung-po
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 55
[10] Tofacitinib for the treatment of psoriasis and psoriatic arthritis
Berekmeri, Anna
Mahmood, Farrouq
Wittmann, Miriam
Helliwell, Philip
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (09) : 719 - 730

← 1 2 3 4 5 →